MANDRIOLI, Jessica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.244
AS - Asia 15.543
EU - Europa 11.687
SA - Sud America 3.496
Continente sconosciuto - Info sul continente non disponibili 577
AF - Africa 399
OC - Oceania 60
Totale 64.006
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.130
SG - Singapore 4.427
IT - Italia 3.907
CN - Cina 3.635
BR - Brasile 2.681
HK - Hong Kong 2.406
GB - Regno Unito 2.194
VN - Vietnam 1.940
DE - Germania 1.006
SE - Svezia 983
FI - Finlandia 912
BD - Bangladesh 729
RU - Federazione Russa 640
KR - Corea 585
CA - Canada 507
FR - Francia 372
BG - Bulgaria 333
AR - Argentina 320
ID - Indonesia 319
IN - India 319
NL - Olanda 286
UA - Ucraina 262
TR - Turchia 228
MX - Messico 165
EC - Ecuador 137
JP - Giappone 129
IQ - Iraq 124
ZA - Sudafrica 115
AT - Austria 114
ES - Italia 98
LT - Lituania 96
CO - Colombia 95
CR - Costa Rica 85
PL - Polonia 84
IE - Irlanda 79
PK - Pakistan 78
CZ - Repubblica Ceca 73
MY - Malesia 68
PY - Paraguay 68
CL - Cile 66
AE - Emirati Arabi Uniti 64
IL - Israele 59
BE - Belgio 56
PH - Filippine 55
JM - Giamaica 51
MA - Marocco 51
EG - Egitto 50
AU - Australia 49
VE - Venezuela 49
TT - Trinidad e Tobago 48
SA - Arabia Saudita 41
TN - Tunisia 39
UZ - Uzbekistan 39
PE - Perù 37
AZ - Azerbaigian 33
KE - Kenya 33
SV - El Salvador 33
HN - Honduras 32
DZ - Algeria 31
GT - Guatemala 30
NI - Nicaragua 30
PR - Porto Rico 30
TH - Thailandia 29
UY - Uruguay 29
CH - Svizzera 28
NP - Nepal 25
BZ - Belize 23
IR - Iran 23
RO - Romania 23
TW - Taiwan 23
DO - Repubblica Dominicana 22
JO - Giordania 21
KZ - Kazakistan 20
SC - Seychelles 20
CW - ???statistics.table.value.countryCode.CW??? 19
PA - Panama 18
GP - Guadalupe 17
PT - Portogallo 17
ET - Etiopia 16
OM - Oman 16
PS - Palestinian Territory 16
EE - Estonia 13
GR - Grecia 13
GE - Georgia 12
LB - Libano 12
BO - Bolivia 11
BY - Bielorussia 11
AL - Albania 10
BH - Bahrain 10
LV - Lettonia 10
SI - Slovenia 10
BB - Barbados 9
NG - Nigeria 9
KG - Kirghizistan 8
NZ - Nuova Zelanda 8
BA - Bosnia-Erzegovina 7
CI - Costa d'Avorio 7
DK - Danimarca 7
SK - Slovacchia (Repubblica Slovacca) 7
AM - Armenia 6
Totale 63.320
Salva come PNG Salva come JPEG
Città #
Ashburn 4.398
Santa Clara 3.285
Singapore 2.855
Hong Kong 2.380
San Jose 2.163
Fairfield 2.021
Council Bluffs 1.300
Chandler 1.002
Hefei 958
Woodbridge 870
Southend 864
London 848
Houston 818
Helsinki 747
Seattle 715
Wilmington 685
Ho Chi Minh City 647
Beijing 616
Los Angeles 616
The Dalles 614
Nyköping 605
Cambridge 581
Seoul 551
Milan 475
Hanoi 423
New York 419
Ann Arbor 416
Chicago 400
Dearborn 393
Munich 387
Jacksonville 367
Princeton 342
Sofia 321
Modena 319
San Diego 286
São Paulo 266
Buffalo 247
Rome 231
Jakarta 200
Oakland 192
Shanghai 179
Dallas 176
Moscow 164
Toronto 153
North Bergen 141
Boardman 128
Atlanta 119
Bologna 116
Lauterbourg 113
Salt Lake City 111
Orem 104
Carrboro 100
Frankfurt am Main 94
Haiphong 93
Da Nang 92
Redondo Beach 92
Phoenix 88
Naples 85
Rio de Janeiro 84
Newark 82
Eugene 80
Columbus 79
Tokyo 79
Madison 78
Amsterdam 75
Bremen 73
Montreal 73
Piscataway 73
Vienna 71
Brooklyn 70
Warsaw 68
Elk Grove Village 67
Tampa 65
Izmir 64
San José 64
Hillsboro 62
Brasília 60
Norwalk 60
Nuremberg 60
Turin 59
Catania 56
Dublin 55
Denver 54
Florence 54
Curitiba 52
Saint Augustine 52
Baghdad 51
Miami 51
Philadelphia 51
Turku 51
Boston 50
Utrecht 50
San Francisco 49
Johannesburg 47
Kent 47
Secaucus 47
Chennai 46
Reggio Emilia 46
Washington 45
Quito 44
Totale 40.515
Salva come PNG Salva come JPEG
Nome #
Fattori di rischio ambientali e occupazionali per la sclerosi laterale amiotrofica: uno studio caso-controllo di popolazione in Emilia Romagna e Sicilia. 636
Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence 471
Exposure to pesticides and risk of amyotrophic lateral sclerosis: a population-based case-control study 435
FATTORI AMBIENTALI DI RISCHIO DELLA SCLEROSI LATERALE AMIOTROFICA: UNO STUDIO CASO-CONTROLLO DI POPOLAZIONE BASATO SU QUESTIONARI ANAMNESTICI 426
Isolated progressive cognitive impairment and depression in a patient with neuroradiological features suggestive of multiple sclerosis 413
Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis 408
Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study 408
The study of levels from redox-active elements in cerebrospinal fluid of amyotrophic lateral sclerosis patients carrying disease-related gene mutations shows potential copper dyshomeostasis 400
Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study 399
Neurogenic T wave inversion in pure left insular stroke associated with hyperhomocysteinaemia 395
Amyotrophic lateral sclerosis incidence following exposure to inorganic selenium in drinking water: A long-term follow-up 391
Pearls & Oy-sters: rapidly progressive dementia: prions or immunomediated? 388
Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populations 382
Post-infectious sensory neuropathy with anti-GT1a and GQ1b antibodies associated with cold urticaria 379
Riluzole and other prognostic factors in ALS: a population-based registry study in Italy 377
Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. 372
Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study 370
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients 365
Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study 363
Endozepines in recurrent stupor 360
Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study 359
Acute hemichorea as unusual first multiple sclerosis presentation 358
Are environmental exposures to selenium, heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis ? 354
The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: A population based study in Modena, Italy 354
Elevated Levels of Selenium Species in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients with Disease-Associated Gene Mutations 353
Pesticides, polychlorinated biphenyls and polycyclic aromatic hydrocarbons in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a case-control study 351
Amyotrophic lateral sclerosis incidence following exposure to inorganic selenium in drinking water 351
Serial Ultrasound Assessment of Diaphragmatic Function and Clinical Outcome in Patients with Amyotrophic Lateral Sclerosis. 347
Selenium Neurotoxicity and Amyotrophic Lateral Sclerosis: An Epidemiologic Perspective 344
ALS and FTD: Where RNA metabolism meets protein quality control 337
Epidemiologia e fattori ambientali di rischio della sclerosi laterale amiotrofica sporadica: metodologia di uno studio realizzato in ambiente gis. 336
Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries 334
Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 333
VCP AND AUTOPHAGOLYSOSOMAL PATHWAY: GUARDIANS OF PROTEOSTASIS AND STRESS GRANULE DYNAMICS. UNRAVELING THEIR IMPLICATIONS IN ALS 332
Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS) 329
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? 328
Pilot trial of clenbuterol in spinal and bulbar muscular atrophy 326
Primary progressive multiple sclerosis and generalized myasthenia gravis: an uncommon association 325
Hsp90-mediated regulation of DYRK3 couples stress granule disassembly and growth via mTORC1 signaling 321
Selenium neurotoxicity in humans: Bridging laboratory and epidemiologic studies. 320
Central pontine myelinolysis and poorly controlled diabetes: MRI’s hints for pathogenesis 319
Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy 318
Comparison of questionnaire exposure data to land cover map from geographical information system to assess passive exposure to pesticides: a methodological study 313
Amyotrophic lateral sclerosis and sarcoidosis: a difficult differential diagnosis. 311
Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM 309
Tolosa-Hunt syndrome due to actinomycosis of the cavernous sinus: The infections hypothesis revisited 307
Amyotrophic lateral sclerosis: Prognostic indicators of survival 304
Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence? 303
High‐frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial 301
Bilateral posterior medullary and cervical stroke: a case report 300
Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis. 298
Risk of ALS and passive long-term residential exposure to pesticides: a population based study. 298
A CASE-CONTROL STUDY OF NEUROTOXIC METALS IN CEREBROSPINAL FLUID AND RISK OF AMYOTROPHIC LATERAL SCLEROSIS 298
Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis: Clinical Protocol and Evaluation of Microbiota Immunity Axis 297
Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 295
Internal carotid artery dissection: a rare cause of peripheral facial nerve palsy 292
Pesticidi e rischio di sclerosi laterale amiotrofica: il contributo della metodologia gis in uno studio in Emilia-Romagna e in Sicilia. 292
L’impiego della ventilazione meccanica non invasiva (VNI) nel trattamento dell’insufficienza respiratoria acuta (IRA) nei pazienti con sclerosi laterale amiotrofica (SLA) 289
Non-invasive and invasive ventilation and enteral nutrition for ALS in Italy. 288
The wide spectrum of cerebrotendinous xanthomatosis: Case report of a rare but treatable disease 287
Rapidly progressive amyotrophic lateral sclerosis in a young patient with hereditary neuropathy with liability to pressure palsies 286
C9ORF72 and parkinsonism: Weak link, innocent bystander, or central player in neurodegeneration? 280
Selenium species and heavy metals in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: a hospital-based case-control study 280
Pesticidi organoclorurati, bifenili policlorurati e idrocarburi aromatici policiclici nel liquido cefalorachidiano di pazienti con sclerosi laterale amiotrofica: uno studio caso-controllo 280
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial 279
Spasmodic dysphonia as a presenting symptom of spinocerebellar ataxia type 12 279
Influence of selenium on the emergence of neuro tubule defects in a neuron-like cell line and its implications for amyotrophic lateral sclerosis 279
Human microglia synthesize neurosteroids to cope with rotenone-induced oxidative stress 278
Pearls & Oy-sters: Paroxysmal dysarthria-ataxia syndrome: Acoustic analysis in a case of antiphospholipid syndrome 278
BAG3 and BAG6 differentially affect the dynamics of stress granules by targeting distinct subsets of defective polypeptides released from ribosomes 277
Living near waterbodies as a proxy of cyanobacteria exposure and risk of amyotrophic lateral sclerosis: a population based case-control study 275
Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study 270
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 270
Population density and risk of Amyotrophic Lateral Sclerosis: an Italian population-based study. 268
Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment 268
Environmental risk factors for amyotrophic lateral sclerosis: methodological issues in epidemiologic studies 266
Environmental and occupational risk factors of amyotrophic lateral sclerosis: a population-based case control study 266
Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: A multicentre Italian study 266
Case report: p.Glu134del SOD1 mutation in two apparently unrelated ALS patients with mirrored phenotype 265
Exposure to inorganic selenium in drinking water and incidence of amyotrophic lateral sclerosis: a long-term follow-up of a natural experiment 265
Comment on 'Huntington's disease presenting as ALS' 263
Do flavan-3-ols from green tea reach the human brain? 260
Duplication of exons 15 and 16 in Matrin-3: a phenotype bridging amyotrophic lateral sclerosis and immune-mediated disorders 260
Selenoprotein P Concentrations in the Cerebrospinal Fluid and Serum of Individuals Affected by Amyotrophic Lateral Sclerosis, Mild Cognitive Impairment and Alzheimer’s Dementia 256
Trace element species and amyotrophic lateral sclerosis with disease associated genetic mutations 256
I pesticidi quali possibili fattori ambientali di rischio nella sclerosi laterale amiotrofica: uno studio caso-controllo di popolazione in Emilia-Romagna. 256
Environmental and occupational exposure to heavy metals and metalloid and development of amyotrophic lateral sclerosis: a population-based case control study in Emilia-Romagna and Sicily. 254
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD 254
Sensory Loss Mimicking Cauda Equina Syndrome due to Cervical Spinal Lesion in a Patient with Clinically Isolated Syndrome 252
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 247
SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study 246
Livelli di piombo, cadmio e mercurio nel liquido cerebrospinale e rischio di sclerosi laterale amiotrofica: uno studio caso-controllo. 245
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 243
Redox speciation of iron, manganese, and copper in cerebrospinal fluid by strong cation exchange chromatography – sector field inductively coupled plasma mass spectrometry 239
Acute hemichorea as unusual first multiple sclerosis presentation: two case reports 239
Risk of ALS and passive residential exposure to pesticides: a population based study. 232
Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggressive disease phenotype 229
A novel p.N66T mutation in exon 3 of the SOD1 gene: report of two families of ALS patients with early cognitive impairment 228
Rapamycin treatment for amyotrophic lateral sclerosis protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 226
Changes in routine laboratory tests and survival in amyotrophic lateral sclerosis 224
Totale 31.333
Salva come PNG Salva come JPEG
Categoria #
all - tutte 276.112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 276.112
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.885 0 0 0 0 83 201 166 198 628 389 720 500
2022/20233.431 505 366 209 387 331 405 115 315 375 54 211 158
2023/20243.899 75 144 189 385 686 228 383 648 127 148 237 649
2024/202512.161 332 103 172 954 1.903 2.065 645 511 1.765 818 1.261 1.632
2025/202622.649 1.480 986 2.253 3.305 2.304 1.218 2.435 1.607 2.356 1.992 1.711 1.002
2026/20279.320 1.354 1.780 2.696 2.860 630 0 0 0 0 0 0 0
Totale 64.006